Dr. Darrell Jackson is an Associate Professor at Washington State University, Spokane, since 2019, where he has been teaching pharmacology to pharmacy, graduate, and undergraduate students. Before joining the Department of Pharmaceutical Sciences in the College of Pharmacy and Pharmaceutical Sciences at Washington State University, Dr. Jackson served as an Associate Professor in the Department of Biomedical Sciences in the College of Pharmacy at the University of Montana (2004-2019), where he taught pharmacology, neuroscience, and neuroanatomy to pharmacy, physical therapy, graduate, and undergraduate students.
Dr. Jackson was an assistant professor at Morehouse School of Medicine (1999-2004) in the Neuroscience Institute and at the College of Pharmacy at Washington State University (Pullman, 1996-1999), where he taught pharmacology to medical and pharmacy students. Following the completion of his doctorate degree in the Department of Pharmacology and Toxicology at Washington State University, where his research focused on investigating the role of serotonin receptors on the excitability of sensory and motoneurons in the spinal cord, Dr. Jackson became a postdoctoral fellow at the Massachusetts Institute of Technology (MIT) and Boston University, investigating the regulation of acetylcholine in the hippocampal brain region.
Before becoming an assistant professor, Dr. Jackson continued his postdoctoral training at the University of Washington in the Department of Pharmacology, where he studied the regulation of muscarinic acetylcholine receptors in heart cardiomyocytes. His current research involves ischemic stroke investigations, specifically studying the neuroprotective effect against ischemia-reperfusion-mediated excitotoxicity in premenopausal females (proestrus cycle) and why this effect is ablated in postmenopausal (acyclic) females.